Free tool
FAERS Monitor: Tresiba
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming BLA 203314 or its brand name (Tresiba, Insulin Degludec). Reports on generic versions are filed under their own applications.
Reports
23,942
Serious
14,201
59% of reports
Hospitalization
7,060
Death reported
1,331
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- blood glucose increased3,805
- nausea1,536
- blood glucose decreased1,309
- drug ineffective1,059
- off label use1,059
- vomiting1,028
- diarrhoea982
- hypoglycaemia981
- fatigue923
- dyspnoea835
- constipation733
- fall726
- dizziness702
- headache678
- abdominal pain611
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2011 | 1 |
| 2013 | 5 |
| 2014 | 54 |
| 2015 | 121 |
| 2016 | 1,013 |
| 2017 | 2,063 |
| 2018 | 2,346 |
| 2019 | 2,124 |
| 2020 | 2,450 |
| 2021 | 2,426 |
| 2022 | 2,114 |
| 2023 | 1,928 |
| 2024 | 2,359 |
| 2025 | 3,106 |
| 2026 | 1,832 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,030,217 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| blood glucose decreasedSignal | 1,309 | 24.6 | 23.3 | 28,859 |
| hypoglycaemiaSignal | 981 | 18.1 | 17.0 | 15,560 |
| blood glucose increasedSignal | 3,805 | 18.1 | 17.6 | 60,706 |
| constipationSignal | 733 | 3.0 | 2.8 | 956 |
| abdominal painSignal | 611 | 2.3 | 2.1 | 457 |
| vomiting | 1,028 | 1.9 | 1.8 | 464 |
| fall | 726 | 1.9 | 1.8 | 323 |
| nausea | 1,536 | 1.7 | 1.6 | 465 |
| diarrhoea | 982 | 1.3 | 1.3 | 86 |
| dyspnoea | 835 | 1.3 | 1.2 | 58 |
| dizziness | 702 | 1.2 | 1.1 | 32 |
| off label use | 1,059 | 1.1 | 1.0 | 4 |
| fatigue | 923 | 1.0 | 1.0 | 2 |
| headache | 678 | 0.9 | 0.9 | 2 |
| drug ineffective | 1,059 | 0.7 | 0.7 | 138 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.